Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In a phase 2 trial, people with T2D and overweight/obesity achieved greater mean WL with cagrisema 2.4 mg compared to cagrilintide 2.4 mg or semaglutide 2.4 mg alone after 32 weeks of treatment (15.6% WL vs
This distinction matters for several reasons
Are there any risks I should be aware of
Do not take these medications if you or a family member has a history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2)
That level of engagement is uncommon in the telehealth GLP-1 space and suggests genuine clinical oversight, not a rubber stamp
US$ 26.33
US$ 26.73
US$ 27.73
